cycloserine and Panic Disorder
cycloserine has been researched along with Panic Disorder in 15 studies
Research
Studies (15)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (26.67) | 29.6817 |
2010's | 9 (60.00) | 24.3611 |
2020's | 2 (13.33) | 2.80 |
Authors
Authors | Studies |
---|---|
Alavi, N; Baird, SO; Dutcher, CD; Kauffman, BY; Lee-Furman, E; Otto, MW; Papini, S; Piper, ME; Rosenfield, B; Rosenfield, D; Smits, JAJ; Zvolensky, MJ | 1 |
Browning, M; Harmer, CJ; Nickless, A; Reinecke, A | 1 |
Cath, DC; Denys, DA; Duits, P; Hofmeijer-Sevink, MK; Hoogendoorn, AW; Rijkeboer, MM; van Balkom, AJ; van den Hout, MA; van Megen, HJ; Vulink, NC | 1 |
Carpenter, A; Leyfer, O; Pincus, D | 1 |
Alt, I; Fehm, L; Fydrich, T; Mumm, J; Plag, J; Pyrkosch, L; Ströhle, A | 1 |
Kauffman, BY; Lee-Furman, E; Otto, MW; Piper, ME; Powers, MB; Rosenfield, D; Smits, JA; Zvolensky, MJ | 1 |
Dowd, SM; Gueorguieva, R; Hofmann, SG; Krystal, JH; Otto, MW; Pearlson, G; Pollack, MH; Simon, NM; Szuhany, KL; Tolin, DF | 1 |
Cordioli, AV; Heldt, E; Manfro, GG; Otto, MW | 1 |
Basden, S; Eisenmenger, K; Hofmann, SG; Krystal, JH; Meunier, SA; Otto, MW; Pearlson, GD; Pollack, MH; Simon, NM; Tolin, DF | 1 |
Diemer, J; Domschke, K; Vennewald, N; Zwanzger, P | 1 |
Choi, DC; Gerardi, M; Ressler, KJ; Rothbaum, BO | 1 |
Finck, C; Golfels, F; Halisch, A; Plag, J; Räth, D; Siegmund, A; Ströhle, A | 1 |
Birk, L | 1 |
Deveney, C; Otto, MW | 1 |
Hofmann, SG | 1 |
Reviews
6 review(s) available for cycloserine and Panic Disorder
Article | Year |
---|---|
[Cognitive-behavioral therapy in panic disorder].
Topics: Agoraphobia; Antimetabolites; Cognitive Behavioral Therapy; Cycloserine; Humans; Panic Disorder; Recurrence; Treatment Outcome | 2008 |
Therapy-refractory panic: current research areas as possible perspectives in the treatment of anxiety.
Topics: Antimetabolites; Biomedical Research; Cognition; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Humans; Panic Disorder; Transcranial Magnetic Stimulation | 2010 |
Pharmacological enhancement of behavioral therapy: focus on posttraumatic stress disorder.
Topics: Animals; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Desensitization, Psychologic; Extinction, Psychological; Eye Movement Desensitization Reprocessing; Humans; Hypnosis; Implosive Therapy; Obsessive-Compulsive Disorder; Panic Disorder; Phobic Disorders; Receptors, N-Methyl-D-Aspartate; Stress Disorders, Post-Traumatic; Treatment Outcome | 2010 |
Pharmacotherapy for performance anxiety disorders: occasionally useful but typically contraindicated.
Topics: Antimetabolites; Anxiety Disorders; Cycloserine; Extinction, Psychological; Fear; Humans; Panic Disorder; Speech; Task Performance and Analysis | 2004 |
Cognitive-behavioral therapy and the treatment of panic disorder: efficacy and strategies.
Topics: Antidepressive Agents; Benzodiazepines; Cognitive Behavioral Therapy; Combined Modality Therapy; Cost-Benefit Analysis; Cycloserine; Humans; Panic Disorder; Treatment Outcome | 2005 |
Enhancing exposure-based therapy from a translational research perspective.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Combined Modality Therapy; Cycloserine; Desensitization, Psychologic; Extinction, Psychological; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Phobic Disorders | 2007 |
Trials
8 trial(s) available for cycloserine and Panic Disorder
Article | Year |
---|---|
Enhancing panic and smoking reduction treatment with D-Cycloserine: A pilot randomized clinical trial.
Topics: Adolescent; Adult; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Double-Blind Method; Female; Humans; Male; Middle Aged; Panic Disorder; Pilot Projects; Smokers; Smoking; Smoking Cessation; Smoking Reduction; Treatment Outcome; Young Adult | 2020 |
Neurocognitive processes in d-cycloserine augmented single-session exposure therapy for anxiety: A randomized placebo-controlled trial.
Topics: Adult; Amygdala; Attentional Bias; Brain; Cycloserine; Drug Partial Agonism; Female; Functional Neuroimaging; Humans; Implosive Therapy; Magnetic Resonance Imaging; Male; Mental Status and Dementia Tests; Middle Aged; Panic Disorder; Reaction Time; Receptors, N-Methyl-D-Aspartate; Severity of Illness Index; Treatment Outcome | 2020 |
No Effects of D-Cycloserine Enhancement in Exposure With Response Prevention Therapy in Panic Disorder With Agoraphobia: A Double-Blind, Randomized Controlled Trial.
Topics: Adult; Agoraphobia; Combined Modality Therapy; Cycloserine; Double-Blind Method; Female; Humans; Implosive Therapy; Male; Panic Disorder; Treatment Outcome; Young Adult | 2017 |
N-methyl-D-aspartate Partial Agonist Enhanced Intensive Cognitive-Behavioral Therapy of Panic Disorder in Adolescents.
Topics: Adolescent; Adult; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Double-Blind Method; Fear; Female; Humans; Implosive Therapy; Male; N-Methylaspartate; Panic Disorder; Parents; Psychotropic Drugs; Treatment Outcome | 2019 |
Enhancing panic and smoking reduction treatment with d-cycloserine: Study protocol for a randomized controlled trial.
Topics: Antimetabolites; Cycloserine; Double-Blind Method; Humans; Implosive Therapy; Panic Disorder; Smoking; Smoking Cessation | 2016 |
RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER.
Topics: Adult; Antimetabolites; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Double-Blind Method; Female; Humans; Male; Middle Aged; Panic Disorder; Treatment Outcome; Young Adult | 2016 |
Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder.
Topics: Adult; Analysis of Variance; Antimetabolites; Cognitive Behavioral Therapy; Cycloserine; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Panic Disorder; Psychiatric Status Rating Scales; Severity of Illness Index; Young Adult | 2010 |
D-cycloserine does not improve but might slightly speed up the outcome of in-vivo exposure therapy in patients with severe agoraphobia and panic disorder in a randomized double blind clinical trial.
Topics: Adult; Agoraphobia; Analysis of Variance; Antimetabolites; Cognitive Behavioral Therapy; Cycloserine; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Panic Disorder; Psychometrics; Statistics, Nonparametric; Treatment Outcome; Young Adult | 2011 |
Other Studies
1 other study(ies) available for cycloserine and Panic Disorder
Article | Year |
---|---|
Learn to forget: Does post-exposure administration of d-cycloserine enhance fear extinction in agoraphobia?
Topics: Adult; Agoraphobia; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Excitatory Amino Acid Agonists; Extinction, Psychological; Female; Follow-Up Studies; Humans; Implosive Therapy; Male; Middle Aged; Outcome Assessment, Health Care; Panic Disorder; Receptors, N-Methyl-D-Aspartate | 2018 |